Display options
Share it on

Infect Immun. 2001 Apr;69(4):2396-401. doi: 10.1128/IAI.69.4.2396-2401.2001.

Profiles of immunoglobulin M (IgM) and IgG antibodies against defined carbohydrate epitopes in sera of Schistosoma-infected individuals determined by surface plasmon resonance.

Infection and immunity

A van Remoortere, G J van Dam, C H Hokke, D H van den Eijnden, I van Die, A M Deelder

Affiliations

  1. Department of Parasitology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

PMID: 11254599 PMCID: PMC98171 DOI: 10.1128/IAI.69.4.2396-2401.2001

Abstract

We report here that sera of children and adults infected with Schistosoma mansoni, S. haematobium, or S. japonicum contain antibodies against GalNAcbeta1-4(Fucalpha1-2Fucalpha1-3)GlcNAc (LDN-DF) and to a lesser extent to Galbeta1-4(Fucalpha1-3)GlcNAc (Lewis(x)) and GalNAcbeta1-4GlcNAc (LDN). Surface plasmon resonance (SPR) spectroscopy was used to monitor the presence of serum antibodies to neoglycoconjugates containing these carbohydrate epitopes and to define the immunoglobulin M (IgM) and IgG subclass distribution of the antibodies. The serum levels of antibodies to LDN-DF are high related to LDN and Lewis(x) for all examined groups of Schistosoma-infected individuals. A higher antibody response to the LDN-DF epitope was found in sera of infected children than in sera of infected adults regardless of the schistosome species. With respect to the subclasses, we found surprisingly that individuals infected with S. japonicum have predominantly IgG antibodies, while individuals infected with S. mansoni mainly show an IgM response; high levels of both isotypes were measured in sera of individuals infected with S. haematobium. These data provide new insights in the human humoral immune response to schistosome-derived glycans.

References

  1. Eur J Biochem. 1994 Oct 1;225(1):467-82 - PubMed
  2. Am J Trop Med Hyg. 1998 May;58(5):543-50 - PubMed
  3. J Immunol. 1988 May 1;140(9):3273-9 - PubMed
  4. Glycobiology. 1998 Jun;8(6):615-24 - PubMed
  5. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4159-63 - PubMed
  6. Biochem Soc Trans. 1997 Aug;25(3):887-93 - PubMed
  7. J Biol Chem. 1995 Jul 21;270(29):17114-23 - PubMed
  8. Eur J Biochem. 1991 May 23;198(1):169-82 - PubMed
  9. Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):410-3 - PubMed
  10. Exp Parasitol. 1996 Mar;82(2):191-200 - PubMed
  11. J Immunol. 1986 Jun 15;136(12):4689-94 - PubMed
  12. J Biol Chem. 1995 Oct 13;270(41):24116-26 - PubMed
  13. Am J Trop Med Hyg. 1989 Mar;40(3):268-72 - PubMed
  14. Glycobiology. 1999 Oct;9(10):1029-35 - PubMed
  15. J Exp Med. 1993 Mar 1;177(3):657-66 - PubMed
  16. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):18-22 - PubMed
  17. FASEB J. 1996 Jun;10(8):838-48 - PubMed
  18. Biochim Biophys Acta. 1999 Oct 8;1455(2-3):363-74 - PubMed
  19. Glycobiology. 2000 Jun;10(6):601-9 - PubMed
  20. Glycobiology. 1997 Jul;7(5):663-77 - PubMed
  21. Exp Parasitol. 1996 Nov;84(2):168-77 - PubMed
  22. Infect Immun. 1996 May;64(5):1826-31 - PubMed
  23. Parasitol Today. 1990 Feb;6(2):45-8 - PubMed
  24. J Biol Chem. 1994 Dec 16;269(50):31510-7 - PubMed
  25. Parasitol Res. 1999 Jan;85(1):14-8 - PubMed
  26. Parasitology. 1996 Jan;112 ( Pt 1):21-35 - PubMed
  27. Blood. 1996 Dec 1;88(11):4246-51 - PubMed
  28. Glycobiology. 1997 Jul;7(5):653-61 - PubMed

Substances

MeSH terms

Publication Types